BLK vs TMO: Which Is the Better Buy?
Side-by-side comparison of BlackRock, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-15.
BlackRock, Inc. · Financial Services
$1,025.44
+31.0% upside to fair value
Grade A
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
BLK has more upside to fair value
(+31.0%).
BLK trades at a lower forward P/E
(24.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BLK |
TMO |
| Current Price |
$1,025.44 |
$464.61 |
| Fair Value Estimate |
$1,343.02 |
$498.27 |
| Upside to Fair Value |
+31.0%
|
+7.2%
|
| Market Cap |
$158.9B |
$172.7B |
| Forward P/E |
24.2x
|
25.2x
|
| EV / EBITDA |
16.0x
|
19.1x
|
| Price / Sales |
5.8x
|
3.8x
|
| Price / FCF |
44.6x
|
25.6x
|
| Revenue Growth YoY |
+30.6%
|
+6.2%
|
| Gross Margin |
54.6%
|
39.4%
|
| Operating Margin |
32.9%
|
17.8%
|
| Return on Equity |
12.5%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.24%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
BlackRock, Inc. is a leading global asset management firm operating within the financial services sector, specializing in investment management and risk advisory. The company demonstrates high business quality with a durable competitive moat supported by strong brand recognition, intangible assets, and switching costs. It reported robust growth in the most recent quarter with revenue up 30.6% yea…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
BLK |
TMO |
| Zone Low |
$1,007.26 |
$373.70 |
| Zone High |
$1,141.57 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|